Buscar resultados de ensayos clínicos
Philadelphia Chromosome - 26 Studies Found
Estado | Estudiar |
No longer available |
Nombre del estudio: Compassionate Use Ponatinib Condición:
|
Completed |
Nombre del estudio: Bioequivalence And Food Effect Study Of Bosutinib In Healthy Subjects Condición: Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML) Fecha: 2011-06-07 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI Condición:
|
Active, not recruiting |
Nombre del estudio: Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia Condición:
|
Completed |
Nombre del estudio: Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia Condición: Leukemia Fecha: 2005-10-25 Intervenciones:
|
Completed |
Nombre del estudio: Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive Leukemias Condición: Chronic Myelogenous Leukemia Fecha: 2008-12-17 Intervenciones: Drug: SKI-606 (Bosutinib) Formulation: 100 mg Capsule for |
Completed |
Nombre del estudio: Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion Condición: Philadelphia Chromosome-positive Chronic Myelocytic Leukemia Fecha: 2009-08-26 Intervenciones: Procedure: Stem cell transplantation Patients were conditioned with oral busulfan 12mg/kg (days -6 to -4 |
Completed |
Nombre del estudio: Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias Condición: Chronic Myeloid Leukemia Fecha: 2005-12-02 Intervenciones: Drug: Bosutinib Part 1, starting dose 400 mg oral, daily d |
Recruiting |
Nombre del estudio: A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL Condición:
|
Completed |
Nombre del estudio: Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy Condición: Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Fecha: 2011-10-14 Intervenciones: Drug: Nilotinib + LDE225 Nilotinib is an aminopyrimidine ATP-competitive inhibitor of the protein tyrosi |